We optimized the BCAT1 and IKZF1 methylation qPCR assays for detection of methylation ratios as low as 0.1%, as such low levels of tumour-derived DNA have been reported in plasma specimens from patients with early stage CRC [4,15]. This evidence concerns the gene IKZF1 and neoplasm.